Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
55.13
-2.24 (-3.90%)
Nov 15, 2024, 4:00 PM EST - Market closed
Revolution Medicines Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
Cash & Equivalents | 201.26 | 696.15 | 161.41 | 108.5 | 104.27 | 16.66 | Upgrade
|
Short-Term Investments | 1,348 | 1,157 | 483.53 | 468.56 | 336.47 | 106.1 | Upgrade
|
Cash & Short-Term Investments | 1,549 | 1,853 | 644.94 | 577.05 | 440.74 | 122.76 | Upgrade
|
Cash Growth | 90.54% | 187.31% | 11.76% | 30.93% | 259.03% | 76.41% | Upgrade
|
Receivables | - | 1.25 | 4.67 | 5.93 | 6.39 | 8.74 | Upgrade
|
Prepaid Expenses | 29.66 | 25.07 | 10.57 | 6.79 | 6.99 | 2.49 | Upgrade
|
Total Current Assets | 1,579 | 1,879 | 660.19 | 589.77 | 454.12 | 133.98 | Upgrade
|
Property, Plant & Equipment | 99.15 | 100.01 | 73.74 | 71.24 | 36.34 | 7.15 | Upgrade
|
Goodwill | 14.61 | 14.61 | 14.61 | 14.61 | 14.61 | 14.61 | Upgrade
|
Other Intangible Assets | 56.94 | 57.74 | 58.81 | 59.88 | 60.95 | 62.01 | Upgrade
|
Long-Term Deferred Charges | - | - | - | 0.5 | - | 2.1 | Upgrade
|
Other Long-Term Assets | 13.16 | 10.06 | 4.59 | 2 | 1.39 | 0.68 | Upgrade
|
Total Assets | 1,763 | 2,062 | 811.93 | 737.99 | 567.4 | 220.53 | Upgrade
|
Accounts Payable | 24.46 | 61.79 | 21.31 | 14.06 | 12.61 | 11.4 | Upgrade
|
Accrued Expenses | 76.73 | 70.8 | 28.94 | 27.41 | 18.69 | 12.87 | Upgrade
|
Current Portion of Leases | 8.4 | 7.37 | 6.77 | 6.21 | 3.67 | 0.2 | Upgrade
|
Current Unearned Revenue | - | - | 4.46 | 12.36 | 12.11 | 17.12 | Upgrade
|
Other Current Liabilities | 1.28 | 3.9 | 0.51 | 0.31 | 0.1 | 1.46 | Upgrade
|
Total Current Liabilities | 110.86 | 143.85 | 61.98 | 60.35 | 47.18 | 43.05 | Upgrade
|
Long-Term Leases | 78.31 | 80.58 | 57.43 | 60.42 | 28.99 | - | Upgrade
|
Long-Term Unearned Revenue | - | - | - | 6.57 | 8.48 | 14.73 | Upgrade
|
Long-Term Deferred Tax Liabilities | 3.12 | 3.12 | 7.03 | 7.44 | 7.44 | 7.82 | Upgrade
|
Other Long-Term Liabilities | 4.41 | 7.97 | 0.3 | 0.63 | 0.63 | 2.4 | Upgrade
|
Total Liabilities | 196.7 | 235.51 | 126.74 | 135.42 | 92.73 | 67.99 | Upgrade
|
Common Stock | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | - | Upgrade
|
Additional Paid-In Capital | 3,106 | 2,963 | 1,388 | 1,056 | 740.1 | 4.74 | Upgrade
|
Retained Earnings | -1,543 | -1,138 | -701.34 | -452.64 | -265.55 | -157.39 | Upgrade
|
Comprehensive Income & Other | 3.81 | 0.54 | -1.78 | -0.38 | 0.12 | 0.07 | Upgrade
|
Total Common Equity | 1,566 | 1,826 | 685.19 | 602.57 | 474.68 | -152.57 | Upgrade
|
Shareholders' Equity | 1,566 | 1,826 | 685.19 | 602.57 | 474.68 | 152.54 | Upgrade
|
Total Liabilities & Equity | 1,763 | 2,062 | 811.93 | 737.99 | 567.4 | 220.53 | Upgrade
|
Total Debt | 86.71 | 87.94 | 64.21 | 66.63 | 32.66 | 0.2 | Upgrade
|
Net Cash (Debt) | 1,463 | 1,765 | 580.74 | 510.42 | 408.08 | 122.56 | Upgrade
|
Net Cash Growth | 94.95% | 203.93% | 13.78% | 25.08% | 232.97% | 76.50% | Upgrade
|
Net Cash Per Share | 9.17 | 15.60 | 7.20 | 7.01 | 7.44 | 44.20 | Upgrade
|
Filing Date Shares Outstanding | 168.22 | 164.69 | 90.49 | 74.19 | 73.38 | 59 | Upgrade
|
Total Common Shares Outstanding | 167.75 | 164.67 | 90.41 | 74.14 | 66.6 | 3.29 | Upgrade
|
Working Capital | 1,468 | 1,735 | 598.2 | 529.42 | 406.95 | 90.93 | Upgrade
|
Book Value Per Share | 9.34 | 11.09 | 7.58 | 8.13 | 7.13 | -46.35 | Upgrade
|
Tangible Book Value | 1,495 | 1,754 | 611.77 | 528.08 | 399.12 | -229.2 | Upgrade
|
Tangible Book Value Per Share | 8.91 | 10.65 | 6.77 | 7.12 | 5.99 | -69.62 | Upgrade
|
Machinery | 32.29 | 28.09 | 21.74 | 14.98 | 11.6 | 9.36 | Upgrade
|
Construction In Progress | 0.09 | 0.51 | - | 0.13 | 1.98 | - | Upgrade
|
Leasehold Improvements | 14.1 | 11.95 | 11.4 | 7.25 | 3.39 | 3.34 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.